Several major companies reported first-quarter and second-quarter 2025 earnings results that surpassed market expectations. BWX Technologies posted adjusted EPS of $0.91 and sales of $682.26 million, beating estimates of $0.75 and $644.46 million, respectively. Air Lease reported adjusted EPS of $1.51 and sales of $738.28 million, exceeding estimates of $0.94 and $710.23 million. Fresenius Medical Care, the world's largest dialysis specialist, reported adjusted EPS of $0.44 and sales of $5.13 billion, surpassing estimates of $0.38 and $4.74 billion, with organic revenue growth across all segments. American Electric Power reported adjusted EPS of $1.54 and sales of $5.46 billion, beating estimates of $1.40 and $5.17 billion. Zoetis delivered adjusted EPS of $1.48 and revenue of $2.2 billion, exceeding estimates of $1.39 and $2.19 billion, driven by 9% organic revenue growth led by companion animal products such as Simparica Trio, Apoquel, Cytopoint, Librela, and Solensia. Zoetis also raised its EPS guidance alongside a projected 6-8% top-line growth. Astera Labs reported a 144% year-over-year revenue increase to $159.4 million and adjusted EPS of $0.33, beating estimates of $152 million and $0.28, respectively. The company guided second-quarter revenue between $170 million and $175 million, representing 124% growth year-over-year, above the prior estimate of 108% growth to $160 million. Emerson Electric posted second-quarter adjusted EPS of $1.48 and revenue of $4.43 billion, beating estimates of $1.42 and $4.39 billion, with record adjusted EBITA margins and strong free cash flow attributed to portfolio transformation and AspenTech integration. Emerson's full-year EPS guidance was revised downward to a range of $4.05 to $4.20 from $4.42 to $4.62, while third-quarter adjusted EPS guidance was set between $1.48 and $1.52, slightly below estimates. Other companies beating earnings and sales estimates included Axcelis Technologies, Bowhead Specialty Holding, Bioventus, Masimo, Bowman Consulting Group, Astronics, Elanco Animal Health, BorgWarner, and Bruker.